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Abstract 
Aspergillus fumigatus is a model fungal pathogen and a common cause of severe infections and 
diseases. CD8+ T cells are present in the human and murine T cell repertoire to the fungus. 
However, CD8+ T function in infection as well as the molecular mechanisms that control their 
priming and differentiation into effector and memory cells in vivo remains elusive. In this study, we 
report that both CD4+ and CD8+ T cells mediate memory protective responses to the fungus 
contingent upon the nature of the fungal vaccine. Mechanistically, class I MHC-restricted, CD8+ 
memory T cells were activated through TLR3 sensing of fungal RNA by cross-presenting dendritic 
cells. Genetic deficiency of TLR3 was associated with susceptibility to aspergillosis and 
concomitant failure to activate memory protective CD8+ T cells both in mice and in stem cell-
transplanted patients. Thus, TLR3 essentially promotes antifungal memory CD8+ T cell responses 
and its deficiency is a novel susceptibility factor for aspergillosis in high-risk patients. 
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Introduction 
Toll-like receptor 3 (TLR3) plays a key role in modulating inflammation and innate immunity in 
the airway. Although best known for recognition of viral double stranded RNA (dsRNA) and its 
synthetic analog polyinosinic:polycytidylic acid [poly(I:C)],1 TLR3 also recognizes endogenous 
ligands2 including heterologous RNA released from or associated with necrotic cells or 
generated by in vitro transcription.3 Thus, TLR3, together with other intracellular signaling 
proteins,4 induces or otherwise modulates innate immune responses and inflammation in settings 
that are not associated with viral dsRNA. TLR3 signaling may also modulate adaptive immune 
responses by providing cross-priming of cytotoxic T lymphocytes through signaling in DCs5-6 
via type I IFNs7 and in the absence of CD4+ T cell help.8 Thus, it is not surprising that 
individuals with mutations in key TLR3 signaling components have a selective 
immunodeficiency manifested by recurrent episodes of Herpes simplex virus 1 encephalitis9-10 or 
enteroviral myocarditis/cardiomyopathy.11 
Aspergillus fumigatus is a model fungal pathogen and a common cause of severe 
infections and diseases. Humans inhale hundreds of conidia everyday without adverse 
consequences,12 except for a minority of persons in whom defense systems fail and a life-
threatening form of disease can develop. CD4+ and CD8+ T cells are present in the human T cell 
repertoire to the fungus13-15 and adoptive transfer of A. fumigatus-specific CD4+ T cells 
conferred protection against invasive fungal infection.15-16 Recent studies indicate a role for 
TLR3 in murine aspergillosis. By functioning as an endogenous sensor of fungal RNA,17 TLR3 
mediates expression of the enzyme indoleamine 2,3-dioxygenase (IDO) on both epithelial18 and 
DCs,19 contributing to the local regulation of innate and adaptive inflammation to the fungus. 
However, the findings that protective memory CD8+ T cells are induced against fungi20-23 
suggest a possible role for TLR3 in activating memory CD8+ T cell-mediated immunity to the 
fungus. 
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We evaluated the contribution of TLR3 to the activation of CD8+ T cells to A. fumigatus in 
preclinical models of aspergillosis and in hematopoietic stem cell transplanted (HSCT) patients with 
a single nucleotide polymorphism (SNP) in TLR3. We found that TLR3 on murine and human DCs 
sorts fungal RNA for activation of class I-restricted protective memory CD8+ T cell responses to the 
fungus. TLR3 deficiency was associated with severe infection in mice and a TLR3 SNP resulting in 
a loss-of-function phenotype of DCs was associated with increased susceptibility to aspergillosis 
and concomitant failure to activate antifungal CD8+ T cells in HSCT patients. 
 
Materials and methods 
Mice 
Female C57BL/6 mice (Charles River, Calco, Italy) and homozygous Tlr3–/– mice on the C57BL/6 
background were bred under pathogen-free conditions in the Animal Facility of the University of 
Perugia, Perugia, Italy and experiments were performed according to the Italian Approved Animal 
Welfare Assurance A-3143-01. 
Fungal and bacterial strains, infections and treatments 
Viable resting and swollen conidia from the A. fumigatus Af293 strain were obtained as described.19 
A GFP-expressing strain of A. fumigatus (provided by M.M. Moore, Department of Biological 
Sciences, Simon Fraser University, Burnaby, British Columbia, Canada) was used to track viable 
fungi. Infection and bronchoalveolar lavage (BAL) morphometry (at least 200 cells per cytospin 
preparation were counted) were performed as described.19 Mice were monitored for fungal growth 
(CFU/organ, mean ± SE), histopathology [periodic acid-Schiff (PAS) and Gomori’s methenamine 
silver staining of lung tissue sections] and lung immunofluorescence (see below). Histology 
sections and cytospin preparations were observed using a BX51 microscope (Olympus, Milan, 
Italy) and images were captured using a high-resolution DP71 camera (Olympus). Poly(I:C) 
(Sigma-Aldrich, St. Louis, MO) was given (50 µg) twice i.p. the day of and a day after infection. 
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Control mice received PBS. Mice were treated with 300 µg of anti-CD4 (GK 1.5) or anti-CD8 
(YTS 169) mAbs (provided by L. Boon, Bioceros BV, Netherlands) the day before and one and 
three days after infection. Control mice received isotype control rat IgG2a mAb (eBR2a) 
(eBioscience, San Diego, CA). Depletion of the corresponding T cell subsets with this regimen was 
monitored in each experiment and was consistently between 95 to 98%, lasting for at least 3 days 
after treatment (data not shown). Mice were infected i.n. with the Pseudomonas aeruginosa PAO1 
(ATCC BAA-47) strain. Bacterial CFU/organ (mean ± SE) were quantified by plating lung 
homogenates on trypticase soy agar plates. 
Vaccination models 
Two vaccination models were used, one using live A. fumigatus conidia or purified fungal antigens 
given with murine CpG oligodeoxynucleotide 1862, the other using fungus-pulsed DCs.24 In the 
first model, mice were injected i.n. with 2×107 conidia/20 µl saline 14 days before the infection or 
with 5 µg of the A. fumigatus cell wall glucanase Crf1p, known to induce MHC class II-restricted 
memory antifungal CD4+ Th1 responses13,25 together with 10 nM CpG in 20 µl saline administered 
14, 7 and 3 days before the infection. Mice were immunosuppressed i.p. with 150 mg/kg of 
cyclophosphamide a day before the infection. In the adoptive transfer model, purified lung CD11c+ 
DCs were pulsed with viable resting conidia or fungal RNA together with the cationic lipid N-[1-
(2,3-dioleoyloxypropyl]-N,N,N,-trimethylammonium methylsulfate (DOTAP) (Boehringer 
Mannheim, Mannheim, Germany) in serum Opti-MEM medium (Life Technologies) for 2 h, as 
described.26 For total RNA isolation, mixing with DOTAP and detection inside the cells, see 
Supplemental Materials. DCs were adoptively transferred by i.p. injection (5×105 cells/each 
injection) twice, a week apart, before the i.n. infection. For vaccination with fungal RNA, 10 µg 
fungal RNA + 20 µg DOTAP were administered i.n. three times as above before the infection. A 
total of 300 µg of anti-CD4, anti-CD8, anti-MHC class I-A (34-5-8S), anti-MHC class II (M5/114) 
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mAbs (provided by L. Boon) or control rat IgG2a mAb was administered in concomitance with the 
vaccines. 
Fluorescence microscopy and morphometric analysis 
Mice were perfused with 2 ml of cold PBS and 1:1 OCT (Cryomount Histolab, Gothenburg, 
Sweden). The lung was snap frozen in OCT and 5-µm sections were performed with a 
semiautomatic cryostat (MC4000; Histo-Line Laboratories, Milan, Italy). Rehydrated sections were 
fixed in 4% paraformaldehyde, blocked with 5% BSA and stained with a combination of Alexa 
Fluor 488 anti-mouse CD11c (N418, BioLegend, Campoverde Srl, Milan, Italy) and anti-mouse 
CD3 (17A2, BioLegend) mAbs at room temperature for 1h. 4’-6-Diamino-2-phenylindole (DAPI, 
Molecular Probes, Invitrogen, Milan, Italy) was used to counterstain tissues and to detect nuclei. 
Images were acquired using a fluorescence microscope (BX51 Olympus) with a 40× objective and 
the analySIS image processing software (Olympus). 
Generation of bone marrow chimeras 
Bone marrow chimeras were generated as described18 (detailed in the Supplemental Materials). 
Cell preparation and cultures 
Murine lung cells were isolated as described24 (detailed in the Supplemental Materials). CD4+ or 
CD8+ T cells were isolated after incubation with FITC-labeled anti-CD4 or anti-CD8, followed by 
anti-FITC MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and DCs were isolated with 
MicroBeads (Miltenyi Biotec) conjugated to hamster anti-mouse CD11c mAbs (N418) before 
magnetic cell sorting.24 Upon written informed consent, human PBMCs were isolated using 
Histopaque®-1077 (Sigma-Aldrich) according to manufacturer’s instructions. Human CD141+ 
(BDCA-3)+ DCs were isolated from total PBMCs using the CD141 (BDCA-3) MicroBead Kit 
(Miltenyi Biotec) according to manufacturer’s instructions (see the Supplemental Materials for 
purity and phenotypic analysis). Murine or human cells (106 cells/ml) were pulsed with poly(I:C) 
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(50 µg/ml), viable conidia of A. fumigatus (5:1 cell:fungus ratio), fungal RNA (10 µg) + DOTAP 
(20 µg) or DOTAP alone for 18 h before RNA extraction and flow cytometry. Amphotericin B 
(Sigma-Aldrich) (2.5 µg/ml) was added after 2 h of pulsing to prevent fungal overgrowth. 
Flow cytometry 
Directly conjugated Abs were purchased from BD Pharmingen (San Diego, CA) (see Supplemental 
Materials for details). Cells were analyzed with a FACScan flow cytofluorometer (Becton 
Dickinson, San Jose, CA) equipped with CellQuestTM software. 
Uptake tracking of GFP-expressing A. fumigatus in vivo 
Single cell suspensions were prepared from lungs or draining lymph nodes depleted of T and B 
cells. Cells were immunostained with the CD11c markers and analyzed by flow cytometry. For the 
phagocytosis assay, see Supplemental Materials. 
Antigen presentation in vitro, cytotoxic and conidiocidal assays 
A panel of Ag presentation inhibitors (all from Sigma-Aldrich) at their optimum concentrations was 
added to DCs for 120 min prior to the 2 h pulsing with A. fumigatus conidia or RNA + DOTAP. We 
used 5 µg/ml chloroquine, 100 nM bafilomycin A, 5 µg/ml brefeldin A and 50 µM lactacystin. 
After pulsing, DCs were fixed in 0.4% paraformaldehyde (Sigma-Aldrich) and extensively washed. 
DCs (1×105) were incubated with CD4+ or CD8+ T cells (5×105), purified from lungs a week after 
infection for lymphoproliferation (after 72 h incubation), gene expression, supernatant collection 
and cytolytic activity (after 24 h incubation). DNA synthesis was measured by 3H-thymidine 
labeling (Amersham Biosciences, Milan, Italy) for 6 h. Cytolytic activity was tested using a 
standard 51Cr-release assay15 (see Supplemental Materials for details). Live or heat-inactivated 
(85°C for 30 min) conidia of A. fumigatus were labeled with FUN-1 (5 µM, Molecular Probes, 
Eugene, OR). Because lymphocytes take up FUN-1, cells could not be added directly in this assay. 
FUN-1-stained live conidia were incubated overnight in culture medium alone or with medium 
	   8 
from naïve CD8+ T cells or cells from infected mice either unexposed or exposed to DCs pulsed 
with conidia or fungal RNA and were examined under fluorescence microscopy. Metabolically 
active conidia accumulate orange fluorescence in vacuoles, while dormant and dead conidia stain 
green. 
Proliferative activity of human T lymphocyte clones 
Limiting dilution and proliferation assays were performed as described15 (detailed in the 
Supplemental Materials). 
Western blotting 
Blots of cell lysates were incubated with rabbit polyclonal Abs recognizing phospho-IRF3 (Ser396, 
4D4G) followed by horseradish peroxidase-conjugated anti-mouse or anti-rabbit IgG, as per the 
manufacturer’s instruction (Cell Signaling Technology, Danvers, MA). Immunoblotting for IDO 
was performed with rabbit polyclonal IDO-specific antibody on total lung cells.18 Scanning 
densitometry was done on a Scion Image apparatus. The pixel density of bands was normalized 
against total protein or β-tubulin. 
ELISA and real-time PCR 
The level of cytokines in culture supernatants of DCs was determined by Kit ELISA (R&D 
Systems, Milan, Italy) at 24 h. The detection limits of the assays were <10 pg/ml for IL-12p70, <3 
pg/ml for IL-10, <30 pg/ml for IL-23, <10 pg/ml for IL-17A and <10 pg/ml for IFN-γ. Cell lysis, 
RNA extraction and real-time PCR were performed as described.18-19 Amplification efficiencies 
were validated and normalized against Gapdh or ACTB. Each data point was examined for integrity 
by analysis of the amplification plot. The mRNA-normalized data were expressed as relative 
mRNA expression in treated cells compared to that of unstimulated cells. For details, see 
Supplemental Materials. 
Patients 
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The genetic study included 223 patients undergoing allogeneic HSCT at the University of Perugia, 
Italy, between 2003 and 2010, and respective donors. Patient characteristics are summarized in 
Table S1. Grafts consisted of immunoselected CD34+ peripheral blood cells in all cases and 
transplantation procedures, antifungal prophylaxis and surveillance for fungal infection were 
performed as described27 (for details, see Supplemental Materials). Probable/proven fungal 
infection was defined according to the revised standard criteria from the European Organization for 
Research and Treatment of Cancer/Mycology Study Group. Study approval was provided by the 
local ethics committee and informed written consent was obtained from all participants in 
accordance with the Declaration of Helsinki. 
SNP genotyping 
SNPs were selected from a literature review and public databases based on three selection criteria: 
i) published evidence of association with human diseases, ii) localization to the promoter, 
untranslated or coding regions, and (iii) minor allele frequencies higher than 5% in the Caucasian 
population. Two TLR3 SNPs complied with the selection criteria: +1234C/T (L412F, rs3775291) 
and +95C/A (rs3775296). Genotyping was performed as described27 (for details and primer 
sequences, see Supplemental Materials). 
Statistical analysis 
Student's T-test or analysis of variance (ANOVA) with Bonferroni's adjustment were used to 
determine statistical significance (P<0.05). Data reported are either from one out of three to five 
independent experiments (western blotting and RT–PCR) or pooled from three to five experiments, 
otherwise. The in vivo groups consisted of 6–8 mice/group. Data were analyzed by GraphPad Prism 
4.03 program (GraphPad Software, San Diego, CA). For details on the statistical analysis of genetic 
associations, see Supplemental Materials. 
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Results 
Tlr3–/– mice are highly susceptible to pulmonary aspergillosis 
We evaluated resistance to primary pulmonary aspergillosis and reinfection in Tlr3–/– and C57BL/6 
mice. In the primary infection, fungal growth was higher in the lungs of Tlr3–/– than control mice 
throughout the course of the infection (Figure 1A) and was associated with higher and persistent 
neutrophil recruitment and infiltration in the lung parenchyma and BAL fluids (inset of Figure 1B 
also showing numerous hyphae) and presence of peribronchiolar lymphocyte infiltrations (arrows in 
Figure 1B and immunofluorescence staining). Fungal dissemination was also observed in the brain 
of Tlr3–/– mice (Figure 1A), more than 85% of which survived the infection (data not shown), if not 
immunosuppressed (Figure 2C). Stimulating TLR3 with the poly(I:C) agonist significantly reduced 
both the fungal growth and inflammation in the lungs of C57BL/6 mice (Supplemental Figure 1A-
B), a finding further supporting that TLR3 provides protection in infection. Gene expression 
analysis of the lung confirmed the higher and more persistent inflammatory response in Tlr3–/– than 
control mice, as revealed by the higher mRNA expression of Cxcl1, Cxcl2 and Mpo genes as well as 
of genes for inflammatory cytokines, such as Il1b (Figure 1C). The levels of Ifna1 and Ifnb1 were 
instead lower in Tlr3–/– mice (Figure 1C). In addition, the conidiocidal activity of lung cells was half 
reduced in Tlr3–/– mice compared to the C57BL/6 control (data not shown). Thus, TLR3 contributes 
to the effector activity of lung cells as well as to protection from unintended inflammation. 
Because A. fumigatus is sensed by TLR3 on both epithelial17 and DCs,19 we determined the 
relative contribution of either type of cells to the TLR3-mediated protection by infecting chimeric 
mice with TLR3-deficient hematopoietic or nonhematopoietic cells. TLR3 deficiency in myeloid, 
more than epithelial cells, greatly impaired resistance to the fungus, as revealed by the inability to 
control fungal growth and restrict inflammation (Supplemental Figure 2). Accordingly, DC 
cytokines were altered in Tlr3–/– mice, in that levels of IL-12p70 were lower and those of IL-23 
higher than in C57BL/6 mice (Supplemental Figure 3). Thus, the myeloid-DC compartment is 
dysfunctional in Tlr3–/– mice and this would predict altered T cell priming in infection. 
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CD8+ T cells do not expand in Tlr3–/– mice upon infection 
We evaluated the priming of CD4+ or CD8+ T cells in Tlr3–/– or C57BL/6 mice by assessing the 
expansion of either T cell subset in infection. Both subsets expanded in the lung and the draining 
lymph nodes of infected C57BL/6 mice, whereas CD4+ but not CD8+ T cells expanded in the lung 
and less in the lymph nodes of Tlr3–/– mice (Supplemental Figure 4). Not only were CD8+ T cells 
defective, but CD4+ T helper (Th) cell subsets were also abnormally activated in Tlr3–/– mice, as 
judged by the decreased expression of Tbet/Foxp3 specific transcripts in cells from draining lymph 
nodes (Figure 1D) and the production of IFN-γ/IL-10 in the lung (Figure 1E) and the increased 
expression of the Rorc transcript (Figure 1D) and the corresponding cytokine IL-17A (Figure 1E). 
Thus, besides being required for the expansion of CD8+ T cells, TLR3 is also required for the 
proper CD4+ Th balance in infection. We know that the activation of IDO via the TLR3/TRIF 
pathway confers tolerogenic and Th1-activating potential to lung DCs in murine aspergillosis.18-19 
Consistently, the enzyme was not induced in infection in the lung of Tlr3–/– mice, despite being 
expressed at the basal level (Supplemental Figure 5). Thus, TLR3 likely contributes, through IDO, 
to the promotion of protective tolerance to the fungus in infection as well as to the down-regulation 
of Th17 responses, as already shown in other lung infections.28 
Tlr3–/– mice fail to develop MHC class I-restricted CD8+ T cell responses upon vaccination 
To define the contribution of CD8+ T cells in infection, we evaluated fungal growth and 
histopathology of infected C57BL/6 mice in conditions of CD4+ or CD8+ T cell depletion. Both 
CD4+ and CD8+ T cell depletion impaired antifungal resistance (Figure 2A and B), even though 
with interesting differences. At variance with CD4+ T cell depletion, CD8+ T cell depletion did not 
adversely affect antifungal resistance early in infection as it did late, as revealed by the increased 
fungal burden and concomitant inflammatory pathology in the lung. This finding suggests that 
CD8+ T cells, somehow dispensable in the early phase of the infection, are instead needed for 
optimal clearance of the fungus late in infection, as already demonstrated in other fungal 
	   12 
infections,22 and points to a role for CD8+ T cells in adaptive antifungal immunity. To assess this 
role, we resorted to well-established experimental models of vaccine-induced resistance.24 Mice 
were treated with conidia or the protective recombinant fungal antigen Crf1p24 along with CpG as 
adjuvant and assessed for resistance to subsequent infection in terms of survival, fungal growth and 
pattern of cytokine gene expression. In contrast to control mice, Tlr3–/– mice failed to develop 
vaccine-induced resistance in response to conidia, as revealed by the inability to survive infection 
(Figure 2C), restrict the fungal growth (Figure 2D) and produce protective IFN-γ and IL-10 (Figure 
2E). Surprisingly, however, they developed full resistance upon Crf1p vaccination (Figure 2C-E). 
The ability of TLR3 signaling to provide cross-priming of CD8+ T cells5 in the relative 
absence of CD4+ T cell help8 prompted us to evaluate whether, similarly to what described for other 
fungi,20-21 exogenous fungal antigens would activate memory CD8+ T cells in a MHC class I-
restricted manner and in the relative absence of Th cells. For this purpose, we evaluated vaccine-
induced resistance in conditions of CD4, CD8, and MHC class I or class II ablation by means of 
specific neutralizing antibodies, thus avoiding residual T helper activity of genetically deficient 
mice. We found that blocking CD4 or class II antigens abrogated the resistance induced by 
vaccination with Crf1p in both C57BL/6 (Figure 2F and G) and Tlr3–/– (Figure 2H and I) mice, 
whereas blocking CD8 or class I antigens abrogated the resistance induced by vaccination with 
conidia in C57BL/6 mice, as revealed by the survival (Figure 2F), the fungal growth (Figure 2G) 
and lung histopathology (Supplemental Figure 6). These results indicate that both CD4+ and CD8+ 
T cells mediate memory responses to the fungus, contingent upon the nature of the fungal vaccine, 
and that CD8+- but not CD4+-dependent memory responses to the fungus are defective in the 
absence of TLR3.  
Migratory CCR7+ DCs are defective in Tlr3–/– mice 
Lung DCs transport A. fumigatus conidia or hyphae to the draining lymph nodes where T cell 
priming occurs.29 To assess whether the defective CD8+ T cell expansion in Tlr3–/– infected mice 
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could result from defective priming in the draining lymph nodes, we infected Tlr3–/– and C57BL/6 
mice with a GFP-expressing strain of A. fumigatus and investigated migration of GFP+ DCs from 
the lung to the draining lymph nodes. We found that a population of CD11chigh DCs expressed GFP 
early in the lungs of C57BL/6 (Figure 3A) and, to a lesser extent, in Tlr3–/– mice in which a 
population of CD11clow cells (also CD11bhigh, data not shown) expressed GFP (Figure 3B). While 
still present in the lung, GFP+ DCs also accumulated in the draining lymph nodes of C57BL/6 
(Figure 3A) but not Tlr3–/– mice (Figure 3B). Thus, DCs responsible for T cell priming in the 
draining lymph nodes are defective in Tlr3–/– mice. This was confirmed by flow cytometry analysis 
of lung DCs showing a decreased number of CD103+ cells that poorly express both CD8α and 
CD11b (Figure 3C), as reported.30 
As CCR7, known to be crucially required for CD8+ T cell priming in the lymph nodes,31 is 
up-regulated in DCs upon conidia internalization,32 we have assessed phagocytosis and Ccr7 
expression in Tlr3–/– DCs. We found that, while the phagocytosis percentage was not different (data 
not shown), the ability to internalize more than one conidia was greatly impaired in Tlr3–/– DCs, as 
revealed by the decreased phagocytic index compared to DCs from C57BL/6 mice (Figure 3D). 
Tlr3–/– DCs also failed to up-regulate Ccr7 expression upon phagocytosis in a manner similar to 
control DCs upon blocking phagocytosis (Figure 3E). Thus, TLR3 contributes to Ccr7 expression 
of lung DCs upon conidia phagocytosis, likely conditioning their migratory capacity and priming 
efficiency. 
Recognition of fungal RNA is defective in Tlr3–/– DCs  
TLR3 is present within endocytic vesicles of cross-presenting DC subsets6 where it is activated by 
microbial dsRNA1,33 or endogenous mRNA.2 Fungal RNA is known to activate DCs for vaccine-
induced resistance26 and is recognized by TLR3.17 DCs transfected with fungal RNA expressed 
immunogenic fungal antigens,26 a finding indicating that newly synthesized fungal antigens are 
originated from RNA translation. This was confirmed in experiments in which vaccination of mice 
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with fungal RNA and the cationic lipid DOTAP – known to target dsRNA to endosomal TLR3 and 
to direct antigens into the class I MHC antigen-presentation pathway34 – resulted in the induction of 
fungus-specific CD8+ T cell-mediated resistance (Supplemental Figure 7). Based on these 
assumptions, we comparatively assessed purified DCs from the lung of Tlr3–/– and C57BL/6 mice 
for functional responses to A. fumigatus conidia or fungal RNA in terms of signaling events 
downstream TLR3, such as phosphorylation of IFN regulatory factor 3 (IRF3), cytokine gene 
expression (type I IFNs), maturation (CD80, CD86 and MHC class II expression), ability to prime 
antigen-specific CD4+ or CD8+ T cells in vitro as well as ability to confer resistance upon adoptive 
transfer in vivo. Fungal RNA potently induced IRF3 phosphorylation in C57BL/6 DCs, an activity 
also observed with swollen conidia, but not with resting conidia or DOTAP nor in Tlr3–/– DCs 
(Figure 4A). Fungal RNA also potently activated gene expression of type I IFNs (Figure 4B) and 
induced DC maturation (Figure 4C) in a TLR3-dependent manner. Although conidia similarly 
activated DCs, the residual activity observed in Tlr3–/– DCs suggests the participation of other TLRs 
and/or intracellular RNA sensors in response to conidia. This was confirmed by the ability of 
conidia-pulsed DCs to prime CD4+ T cells in both C57BL/6 (Figure 4D and E) and Tlr3–/– mice 
(Figure 4F and G) and, similar to RNA-pulsed DCs, to activate CD8+ T cells. Indeed, conidia-
pulsed DCs primed both T cell subsets from C57BL/6 mice for proliferation (Figure 4D) and Ifng 
expression (Figure 4E) and primed CD8+ T cells for Prf1 gene expression (Figure 4E). In contrast, 
RNA-pulsed DCs primed only CD8+ T cells for proliferation (Figure 4D), Ifng and Prf1 gene 
expression (Figure 4E), as well as for cytolytic activity against fungus-pulsed DCs (Figure 4H) or 
against the fungus itself (Figure 4I). Of interest, CD8+ T cell priming by RNA-pulsed DCs was 
abrogated in the presence of known inhibitors of the TLR3-dependent antigen presentation 
pathway11 – bafilomycin A1 and chloroquine – and of the cytosolic, class I-dependent antigen 
presentation pathway35 – brefeldin A and lactacystin – (Figure 4J). These findings indicate that both 
the endosomal/lysosomal and proteasomal degradation pathways are involved in antigen processing 
after RNA transfection. Finally, fungus- or RNA-pulsed DCs isolated from Tlr3–/– mice failed to 
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confer protection upon adoptive transfer in vivo in C57BL/6 mice. However, fungus- or RNA-
pulsed DCs from C57BL/6 mice also failed to confer protection upon transfer in Tlr3–/– mice 
(Figure 4K), a finding suggesting that host DCs cross-present fungal antigens from migratory donor 
DCs, as proposed.36 
A TLR3 SNP associates with increased risk of invasive aspergillosis in HSCT recipients 
Given the above results, we investigated whether genetic variants affecting the function of TLR3 
might influence susceptibility to aspergillosis in patients with predisposing conditions. To this 
purpose, we performed a genetic analysis of selected SNPs in TLR3 in a cohort of 223 consecutive 
HSCT recipients and respective donors (Table S1). To estimate risk of infection according to 
patient or donor TLR3 genotypes, we determined cumulative incidences of aspergillosis among 
transplant recipients at 12 months following transplantation. The +1234C/T (L412F) SNP did not 
influence susceptibility to infection when present in either patients [22.1% for CC and 20.3% for 
CT + TT; P=0.73] or donors [24.5% for CC, 15.9% for CT + TT; P=0.19]. In contrast, the +95C/A 
SNP was found to significantly increase risk of aspergillosis when present in donors [14.8% for CC 
and 30.2% for CA + AA; P=0.01] (Figure 5B), but not in patients (22.2% for CC and 19.9% for CA 
+ AA; P=0.89) (Figure 5A). Thus, recapitulating the murine findings, the specific contribution of 
the TLR3 +95C/A SNP to the infection appears to rely on its presence on myeloid cells. Moreover, 
the genetic association remained significant after correction for clinical co-variables, namely 
transplant matching, graft-versus-host disease (GVHD) and antifungal prophylaxis. In the 
multivariate model, donor TLR3 +95C/A SNP (CA + AA genotype) independently increased risk of 
IA [adjusted hazard ratio (HR), 2.41; 95% confidence interval (CI), 1.27–4.58; P=0.007). No 
statistically significant influence of the tested SNPs was observed on patient survival (data not 
shown). 
The TLR3 +95C/A SNP leads to defective CD8+ T cell activation by DCs 
	   16 
Human CD141+ (BDCA-3)+ DCs are known to represent the equivalent of mouse DCs that cross-
present antigens to CD8+ T cells upon treatment with poly(I:C).37 We purified BDCA-3+ DCs from 
individuals bearing distinct TLR3 +95C/A genotypes and assessed TLR3 expression upon 
stimulation with poly(I:C), A. fumigatus conidia or fungal RNA. Phenotypic analysis revealed that 
BDCA-3+ DCs were CD11c+, CD11b-, CD1a-, CD86+ and CD80- (Supplemental Figure 8), as 
described.38 We found that TLR3 mRNA expression in WT BDCA-3+ cells was strongly induced 
following pulsing with each stimulus (Figure 6A). In contrast, BDCA-3+ cells bearing the +95C/A 
SNP displayed instead a marked decrease in TLR3 expression and responsiveness, a defect found to 
be genotype dose-dependent. We also found that expression of both IFNA1 and IFNB1 genes was 
triggered by all the stimuli in WT BDCA-3+ DCs, but not in TLR3 polymorphic cells (Figure 6B). 
Finally, on assessing the ability of BDCA-3+ DCs to prime CD4+ or CD8+ T cells for proliferation, 
we found that antigen-specific (Figure 6C) and, to a lesser extent, polyclonal (Figure 6D) CD8+ T 
cell proliferation were mostly affected by the TLR3 +95C/A SNP compared to CD4+ T cells. Given 
that TLR3 is expressed on CD8+ T cells (ref. 39 and Supplemental Figure 9), we cannot rule out the 
contribution of direct TLR3 signaling to the defective proliferative activity of CD8+ T cells. 
Altogether, these results point to an essential role for TLR3 in the activation of memory protective 
CD8+ T cell responses to A. fumigatus in mice and humans. 
 
Discussion 
The ability of exogenous fungal antigens to activate memory protective CD8+ cells without CD4+ 
T-cell help (“helpless”) is of relevance for both basic and clinical mycology. This demands for a 
better definition of cells and molecules that control CD8+ T cell priming and differentiation into 
effector and memory cells in vivo. The major findings to emerge from these studies are that TLR3 
signaling in DCs pulsed with A. fumigatus conidia or RNA efficiently prime resting CD8+ T cells in 
vivo and in vitro for memory responses to the fungus by a mechanism that appears to involve acidic 
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endosomal vesicles as well as cytosolic processing. Susceptibility to aspergillosis was increased in 
conditions of TLR3 deficiency both in mice and humans, a finding pointing to a previously 
unrecognized role for the TLR3-dependent antigen recognition pathway in aspergillosis. Similarly 
to what was observed with other fungal pathogens,20-21,40 by producing effector cytokines such as 
IFN-γ, and exhibiting cytotoxic activity against fungus-laden cells or the fungus itself, CD8+ T cells 
provided vaccine-induced resistance likely by restricting the fungal growth and terminating the 
cellular response in infection. 
Both CD4+ T cells13-15 and CD8+ T cells13,25,41 are present in the murine and human T cell 
repertoire to the fungus. However, the role of CD8+ T cells in infection, the specific fungal antigens 
they recognize and mechanisms underlying their activation are unknown. Our study provides 
evidence that both CD4+ and CD8+ T cells mediate memory responses to the fungus, contingent 
upon the nature of the fungal vaccine. Indeed, the cell wall glucanase Crf1p, known to be presented 
by three common human MHC class II alleles and to induce memory CD4+ Th1 cells to the 
fungus,42 activated antifungal memory CD4+ Th1 cells independently of TLR3. We have evidence 
that recognition of Crf1p and CD4+ Th1 cell activation occur via MyD88 (unpublished 
observation), a finding suggesting that TLRs, other than TLR3, are involved in fungal antigen 
sampling and signaling for activation of the CD4 arm of the memory immune response to the 
fungus. However, the finding that Tlr3–/– mice failed to mount an efficient memory response to the 
fungus, while retaining the ability to activate memory fungal-antigen specific CD4+ T cell 
responses, points to either a superior activity of the CD8-dependent mechanisms in immune 
memory to the fungus or a dysfunctional fungal processing in conditions of TLR3 deficiency. 
TLR3 is a crucial “danger” signaling receptor that senses endogenous mRNA released by 
necrotic cells.3 Thus, it is possible that TLR3 is activated in infection by sensing host damage. 
However, in this case, CD8α+ DCs are the solely responsible for cross-presenting antigens from 
apoptotic host cells.43 In addition, we have recently shown that TLR3 restrained rather than 
promoted danger-dependent inflammation in aspergillosis.17 Thus, sensing fungal RNA is the likely 
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function of TLR3 in infection. By migrating from early endosomes to LAMP1+ endosomes upon 
stimulation with dsRNA, TLR3 mediates the activation of DCs for the cross-presentation of 
exogenous antigens to CD8+ T cells.6 Thus, TLR3-specific adjuvants are used to tailor CD8+ T cell 
immune responses independently of CD4 help.44 We have tested the adjuvant activity of TLR3 and 
found that administration of Crf1p with poly(I:C) skewed T cell memory from class II-dependent 
CD4+ T cells – obtained with CpG known to block cross-presentation43– to class I-dependent CD8+ 
T cells (data not shown). This finding highlights the importance of adjuvants in skewing antifungal 
memory responses to candidate subunit fungal vaccines. However, the function of fungal RNA may 
go beyond its adjuvant activity as RNA-transfected DCs also originate fungal antigens.26 As in viral 
infection,45 the requirement of host translational machinery could enhance the efficiency of class I 
presentation. We show that these antigens are processed via both the TLR3-dependent 
endosomal/lysosomal and class I-dependent proteasomal degradation pathways. It is also likely that 
direct presentation of fungal antigens, newly synthesized from endogenous RNA produced after 
fungal internalization and degradation, occurs in infection through cytosolic receptors other than the 
endosomal TLR3. Consistent with the findings obtained with conidia, apparently many routes of 
antigen sampling and presentation are used by DCs confronted with the fungus. 
TLR3 may further optimize CD8+ T cell activation by facilitating CCR7 expression on DCs 
through unimpaired phagocytosis. Despite the fact that CCR7 deficiency does not impair fungal 
clearance in primary aspergillosis,46 CCR7+ DCs are required for the priming of CD8+ T cells in the 
draining lymph node and this finding highlights the interesting difference with CD4+ T cell anti-A. 
fumigatus priming that was reported to be mediated by migratory CCR2+ inflammatory 
monocytes.47 However, the role of TLR3 may go beyond regulation of adaptive memory to include 
regulation of inflammation and tolerance. The defective IDO activation likely contributed to the 
inability of these mice to promote tolerogenic responses to the fungus that are required to limit 
inflammation in infection.18 Indeed, IL-17A-producing Th17 cells were expanded in Tlr3–/– mice 
and likely contributed to inflammatory pathology, as suggested.33 Besides the ability of type I IFNs 
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to inhibit Th17 development,48 it is interesting that, disabling lymph node priming, as in CCR7 
deficiency,49 promoted IL-17A–mediated lung pathology via abnormal T cell sensitization in 
ectopic lymph node formation.50 Both defective Ccr7 expression and peribronchiolar lymphoid 
tissues were observed in Tlr3–/– mice. 
In conclusion, this study discloses the contribution of TLR3 to CD8+ T cell memory 
responses to A. fumigatus and identifies a TLR3 SNP leading to a loss-of-function phenotype of 
DCs that is associated with susceptibility to infection and concomitant failure to activate antifungal 
CD8+ T cells in HSCT patients. Our findings may offer a plausible explanation for the increased 
susceptibility to aspergillosis after CMV reactivation in HSCT patients and predict that, in addition 
to TLR9,51 TLR3 SNPs are also a likely risk factor for infection by CMV that, incidentally, shares 
with other members of the Herpes virus family, the ability to subvert endogenous MHC class I 
pathway via TRIF degradation.52 Regardless of possible differences between viral and fungal cross-
presentation pathways, our findings suggest that a defective antigen cross-presentation pathway 
may predispose to both viral and fungal infections in HSCT patients and point to novel therapeutic 
interventions. 
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Figure legends 
Figure 1. Tlr3–/– mice are highly susceptible to pulmonary aspergillosis. C57BL/6 or Tlr3–/– mice 
were infected i.n. with live A. fumigatus conidia (6-8 mice/group). (A) Fungal growth (mean CFU ± 
SE) in the lungs and brains of infected mice was assessed at different days post-infection (dpi). (B) 
Lung histology (PAS staining), BAL morphometry [%, mean ± SD, of MNC or polymorphonuclear 
(PMN) cells] and immunofluorescence of infected mice at different dpi. Note the sustained 
inflammatory cell recruitment in the lungs and BAL (May-Grünwald Giemsa staining in the inset) 
of Tlr3–/– mice as well as the presence of peribronchiolar lymphocyte infiltrates (at 3 dpi) (arrows in 
PAS staining and immunofluorescence images). Cell surface markers used for DC and T cell 
visualization were CD11c (Green-Alexa 488) and CD3 epsilon followed by PE-secondary antibody, 
respectively. Cell nuclei were stained blue with DAPI. Representative images of two independent 
experiments were acquired with a 40× objective. Bars in histology sections indicate magnifications. 
(C) Lung total RNA from infected mice was extracted from naïve (0) or at 1, 3 and 7 dpi and the 
relative expression of Cxcl1, Cxcl2, Mpo, Il1b, Ifna1 and Ifnb1 was assessed by RT-PCR. (D) Total 
RNA was extracted from purified CD4+ T cells from the draining lymph nodes of naïve or infected 
mice at 7 dpi and the relative expression of Tbet, Rorc and Foxp3 was assessed by RT-PCR. (E) 
Total lung homogenates at 3 and 7 dpi were assessed for levels of IFN-γ, IL-17A and IL-10 by 
specific ELISA (mean values ± SD). Data are pooled from 3 independent experiments. *, P<0.05; 
**, P<0.01; ***, P<0.001; infected vs. naïve mice (D) or Tlr3–/– vs. C57BL/6 mice (A, C and E). 
 
 
Figure 2. Tlr3–/– mice fail to develop MHC class I-restricted CD8+ T cell responses upon 
vaccination. (A) C57BL/6 mice were treated with a total of 300 µg of anti-CD4 or anti-CD8 
antibody the day before, 1 or 3 days after the i.n. infection with live A. fumigatus conidia (6-8 
mice/group). None, mice receiving isotype control antibody. Depletion of the corresponding T cell 
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subsets with this regimen was between 95 to 98% at 3 and 7 days post-infection (dpi). (B) PAS 
staining of the lungs from mice treated as above. Note the presence of fungi (Gomori’s 
methenamine silver staining in the inset) and the sustained inflammation in the lungs of CD4-
depleted mice throughout the infection, as opposed to the increased inflammation and fungal growth 
only observed at 7 dpi in CD8-depleted mice. Bars indicate magnifications. (C) Survival (%), (D) 
fungal growth (CFU, mean ± SE) and (E) relative lung expression of Ifng, Il17a, Il4 and Il10 by 
RT-PCR in C57BL/6 or Tlr3–/– mice vaccinated with A. fumigatus conidia 14 days before (blue 
color) or with the recombinant fungal antigen Crf1p + CpG 14, 7 and 3 days (red color) before 
subsequent i.n. infection with live conidia (6-8 mice/group). Mice were given cyclophosphamide a 
day before the infection. Fungal growth and gene expression were assessed at 3 dpi. CpG alone 
failed to induce vaccine-induced resistance, as already reported.24 (F, H) Survival and (G, I) fungal 
growth (at 3 dpi) in mice treated with anti-CD4, anti-CD8, anti-MHC class I or anti-MHC class II 
mAbs in concomitance with A. fumigatus conidia vaccination (blue color) or Crf1p + CpG 
vaccination (red color). Treatment with anti-CD4 alone, but not anti-CD8, anti-MHC class I-A or 
anti-MHC class II mAbs alone, further increased the susceptibility to the infection in 
cyclophosphamide-treated mice compared to control mice. Ct, infected unvaccinated mice. None, 
vaccinated mice treated with an isotype control antibody. Bars indicate magnifications. Data are 
representative from at least 3 independent experiments. *, P<0.05; **, P<0.01; ***, P<0.001; 
vaccinated vs. unvaccinated mice (D and E) or treated vs. untreated mice (A, G and I). 
 
Figure 3. Migratory CCR7+ DCs are defective in Tlr3–/– mice. (A) C57BL/6 or (B) Tlr3–/– mice 
were infected i.n. with GFP-expressing A. fumigatus conidia and the numbers of GFP+ CD11c+ cells 
were assessed by flow cytometry on T- and B-cell depleted lungs or draining lymph nodes at 
different dpi. Numbers (mean values ± SD, n = 3) refer to % positive cells on gated CD11c+ cells. 
Shown is one representative experiment. (C) Phenotype of CD11c+ DCs from naïve C57BL/6 or 
Tlr3–/– mice. Flow cytometry was performed on gated CD11c+ DCs enriched from lungs. Numbers 
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(mean values ± SD, n = 3) refer to % positive CD103+ cells. Histograms refer to cells expressing 
CD8α or CD11b on gated CD103+ cells from one representative experiment. Isotype matched rat 
IgG2a (CD8α) or IgG2b (CD11b) control staining is shown in the blue histograms. (D) Phagocytic 
index (n = 3) and (E) relative expression of Ccr7 (RT-PCR, mean values ± SD of at least 3 
independent experiments assessed in triplicates) by purified lung DCs. Monolayers of DCs were 
added of live GFP-expressing conidia for 2 h at 37°C. Cytochalasin D was added for 1 h at 37°C 
before phagocytosis. Phagocytosis was quantified via phase contrast and fluorescence microscopy 
using the ×100 objective after quenching the fluorescence of bound uningested conidia with trypan 
blue and the DCs were fixed in 1% paraformaldehyde (shown are representative microscopy images 
of 2 independent experiments). Ct, control, unexposed cells. 
 
Figure 4. Recognition of fungal RNA is defective in Tlr3–/– DCs. C57BL/6 or Tlr3–/– lung DCs 
from naïve mice were left unpulsed (None) or pulsed with resting (RC) or swollen (SC) A. 
fumigatus conidia, DOTAP alone or fungal RNA + DOTAP for 2 h. (A) Phosphorylation of IRF3 
(p-IRF3) in DCs pulsed as above. Shown is a representative Western blot out of 3 independent 
experiments. The IRF3 bands were quantified and the ratios of phosphorylated to total IRF3 are 
shown. (B) Relative expression of Ifna1 and Ifnb1 (RT-PCR) and (C) expression of CD80, CD86 
and MHC class II (flow cytometry) on pulsed DCs (mean values ± SD of at least 3 independent 
experiments assessed in triplicates). Flow cytometry was performed 6 h after pulsing and results are 
expressed as % positive cells. (D, F) T cell proliferation induced by conidia- or RNA-pulsed DCs in 
CD4+ or CD8+ T cells purified from lungs of (D) C57BL/6 or (F) Tlr3–/– mice, a week after the i.n. 
infection and assessed for lymphoproliferation after 72 h co-culture with pulsed-DCs from naïve 
mice. DNA synthesis was measured by 3H-thymidine uptake (cpm, counts per minute). Ct, pulsed 
DCs alone. (E, G) Relative expression of Ifng and Prf1 by RT-PCR in CD4+ and CD8+ T cells 
exposed to conidia- or fungal RNA-pulsed DCs for 24 h from (E) C57BL/6 or (G) Tlr3–/– mice. (H) 
Cytolytic activity of CD8+ T cells from C57BL/6 mice, obtained as in D, against conidia-pulsed 
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DCs at different effector cell to target cell (E:T) ratios. Shown is the % specific cytotoxic activity 
determined by a standard 4h 51Cr-release assay. (I) Conidiocidal activity of culture supernatants 
from CD8+ T cells exposed as in H. Live conidia were labeled with the fluorescent molecular stain 
FUN-1 and incubated overnight with culture medium from cultured CD8+ T cells before 
examination by fluorescence microscopy. Metabolically active conidia accumulate orange 
fluorescence in vacuoles, while dormant and dead conidia stain green. Shown are representative 
fluorescence microscopy images of 3 independent experiments. (J) CD8+ T cell proliferation 
induced by RNA-pulsed C57BL/6 DCs in the presence or not (–) of inhibitors targeting class II 
(bafilomycin A1 and chloroquine) or class I (brefeldin A and lactacystin) antigen presentation 
pathways. Ct, CD8+ T cells alone. (K) Adoptive transfer of C57BL/6 or Tlr3-/- DCs pulsed with 
conidia or fungal RNA into C57BL/6 or Tlr3–/– mice. DCs were adoptively transferred by i.p. 
injection twice, a week apart, before the infection. Fungal growth in the lungs (mean CFU ± SE, 
representative of at least 3 independent experiments) was assessed 3 days after the i.n. infection. In 
vivo data are from 4 independent experiments assessed in triplicates. *, P<0.05; **, P<0.01; ***, 
P<0.001, Tlr3–/– vs. C57BL/6 mice (B and C), antigen-pulsed DC-primed vs. unpulsed DC-primed 
(None) T cells (D, E, F and G), stimulated vs. unstimulated CD8+ T cells (H), inhibitors vs. no 
inhibitors (-) (J) and DC-treated vs. untreated (None) mice (K). 	  
Figure 5. A TLR3 SNP associates with increased risk of invasive aspergillosis in stem cell 
transplanted recipients. The TLR3 +95C/A genotype of 223 consecutive hematological patients 
undergoing allogeneic stem cell transplantation and respective donors was determined by the 
bidirectional PCR amplification of specific alleles (Bi-PASA) method and correlated with the 
incidence of invasive aspergillosis. (A) Cumulative incidence of invasive aspergillosis at 12 months 
according to patient +95C/A genotype: CC (22.2%, n=123) and CA + AA (19.9%, n=66), P=0.70 
(B) Cumulative incidence of invasive aspergillosis at 12 months according to donor +95C/A 
genotype: CC (14.8%, n=109) and CA + AA (30.2%, n=80), P=0.01. 
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Figure 6. The +95C/A SNP in TLR3 associates with defective CD8+ T cells by peripheral DCs. 
Human CD141+ (BDCA-3+) DCs were isolated from peripheral blood of healthy volunteers bearing 
distinct TLR3 +95C/A genotypes (CC, CA and AA) and were either left untreated or pulsed with 
poly(I:C), A. fumigatus conidia or fungal RNA. Relative expression of (A) TLR3 and (B) type I 
IFNs (IFNA1 and IFNB1) was assessed by RT-PCR. (C) Frequencies of antigen-specific CD4+ or 
CD8+ T cell clones were obtained by limiting dilution assays. Antigen-specific proliferation of T 
cell clones was assessed after co-culture of responder CD4+ and CD8+ T cells with BDCA-3+ DCs 
pulsed with A. fumigatus conidia or fungal RNA and measured by 3H-thymidine incorporation. 
Shown are % CD4+ or CD8+ T cell clones/106 cells. (D) Purified T cell subsets were stimulated 
with 0.1% PHA in the presence of autologous PBMCs. DNA synthesis was measured by 3H-
thymidine uptake (cpm, counts per minute). None, untreated DCs. Ct, T cells alone. Data are mean 
values ± SD of at least 3 independent samples for each +95C/A genotype assessed in triplicates. *, 
P<0.05; **, P<0.01; ***, P<0.001; treated vs. untreated (None) BDCA-3+ DCs. 
 
